Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies Post author: Post published:November 1, 2023 Post category:uncategorized Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications. You Might Also Like Researchers create random versions of human genomes to study disease January 31, 2025 Study finds increasing rates of therapy-related acute myeloid leukemia April 6, 2026 Discovery of cyclotide from violets enhances glioblastoma chemotherapy September 30, 2024